Thieme E-Books & E-Journals -
Diabetologie und Stoffwechsel 2025; 20(S 01): S44
DOI: 10.1055/s-0045-1807441
Abstracts | DDG 2025
Poster
Posterwalk 5: Diabeteskomplikationen I Niere I Fuß

Near-Normoglycemia and Insulin Regression Induced by Tirzepatide in Basal Insulin–Treated Type 2 Diabetes

Authors

  • J Rosenstock

    1   Velocity Clinical Research at Medical City, Senior Scientific Advisor, Dallas, Texas, United States
  • S Tofé

    2   Department of Endocrinology and Nutrition, University Hospital Son Espases, Palma, Spain
  • C Wysham

    3   Rockwood Clinic, Department of Diabetes and Endocrinology, Spokane, United States
  • V Thieu

    4   Eli Lilly and Company, Cardiometabolic Health-Incretins, Indianapolis, United States
  • J Kiljanski

    5   Eli Lilly and Company, Cardiometabolic Health, Indianapolis, United States
  • C Lee

    6   Eli Lilly and Company, Global Medical Affairs Obesity/NILEX, Indianapolis, United States
  • H Wang

    7   TechData Service Company LLC, TechData Service Company LLC, Philadelphia, United States
  • H Patel

    8   Eli Lilly and Company, Type 2 Diabetes Development, Indianapolis, United States
  • J Simon

    9   MVZ im Altstadt-Caree Fulda GmbH, Specialist in internal medicine, diabetology, sports medicine, preventive medicine, Fulda, Germany